Dextromethorphan (Delsym) vs. Other Cough Suppressants
Dextromethorphan (Delsym) is the recommended first-line treatment for dry cough with superior efficacy and safety profile compared to other cough suppressants like codeine or pholcodine, which have greater adverse effects despite similar efficacy. 1
Efficacy Comparison
Dextromethorphan (Delsym)
- Acts centrally to suppress the cough reflex 1
- Recommended dosage: 30 mg every 6-8 hours, not exceeding 120 mg in 24 hours 1
- Available in extended-release formulation (Delsym) providing 12-hour cough relief 2
- Shown to reduce cough frequency by 21-25.5% compared to placebo in children 3
- Non-sedating opiate derivative with proven cough suppression in meta-analysis 4
- Maximum cough reflex suppression occurs at 60 mg with prolonged effect 4
Other Cough Suppressants
Codeine/Pholcodine
Menthol
Sedating Antihistamines
Safety Considerations
- Dextromethorphan is generally well-tolerated at recommended doses 3
- Care must be taken with higher doses, especially with combined preparations containing other ingredients like paracetamol 4
- Overdose can be serious, particularly in children - a case report showed life-threatening symptoms with blood concentration exceeding 100 ng/mL 6
- The extended-release polistirex formulation (Delsym) has a duration of action 2-3 times longer than standard formulations 6
- Contains sodium metabisulfite, which may cause allergic-type reactions in sensitive individuals 2
Clinical Application
For dry cough management:
- First-line: Dextromethorphan 30 mg every 6-8 hours (or extended-release formulation for 12-hour coverage) 4, 1, 2
- Alternative for nighttime cough: Sedating antihistamines if sleep disruption is a major concern 4
- Adjunctive therapy: Menthol for short-term relief 4
- Avoid: Codeine or pholcodine due to poor benefit-risk ratio 4, 1
Special Considerations
- For productive cough, guaifenesin (200-400 mg every 4 hours) is recommended instead of dextromethorphan 1
- Simple home remedies like honey and lemon may be beneficial and cost-effective for mild cases 4, 1
- Voluntary suppression of cough may be sufficient in some cases 4
- Cough lasting more than 8 weeks requires evaluation for underlying causes 1
Common Pitfalls
- Using subtherapeutic doses of dextromethorphan (generally recommended OTC doses may be lower than optimal therapeutic doses) 4
- Failing to recognize that extended-release formulations (Delsym) have different dosing schedules than immediate-release products
- Using opiate-based cough suppressants when dextromethorphan would provide similar efficacy with fewer side effects 4, 1
- Treating productive cough with suppressants rather than expectorants 1